SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech
Nabi (NABI)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
354 22 0 NABI
Emcee:  The BayWatcher Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
279TD - I got the press release on Steph late in the morning. Some posters on YahoClouseau-9/19/2000
278Dave, I don't know...but the double whammy they got today doesn't look gArthur Radley-9/19/2000
277TD: I read the reports and am inclined to think that the selling is way overdoneClouseau-9/19/2000
276Bad news from NABI today and stock got killed.Arthur Radley-9/19/2000
275Nabi appears to be cooling off again. I kept a few shares but sold off most betwOak Tree-9/12/2000
274Mike, I mostly agree. First I believe that we can expect prices over $10 (thoughOak Tree-9/3/2000
273Oak Tree, Nabi is on a calendar basis with the third quarter ending 9/31. WouldExtra Pale-9/1/2000
272NABI is heating up again, probably in anticipation of the news that is about to Oak Tree-9/1/2000
271Regarding market size for StaphVax. I can only guess - either large of small. Oak Tree-8/29/2000
270Regarding StaphVax phase III trial: "On May 4, 2000, Nabi announced that itExtra Pale-8/28/2000
269Bad day for biotech. ouch. probably time to buy though.Oak Tree-7/28/2000
268Go back on the thread; the warning letter is summarized quite well. I wouldnTorben Noerup Nielsen-7/26/2000
267Torbin, NABI had a nice second quarter report. What does the $10M private placemOak Tree-7/26/2000
266Nabi fda warningletter fda.govdalroi-7/13/2000
265Could go that high just for bovine use. Assuming efficacy. Humans merely get sicTorben Noerup Nielsen-7/11/2000
264Time horizon, less than two years. Stock to go as high as $70-90. Asumming theirSamuel J. Bennett-7/11/2000
263 Dude, I agree. The earning report convinced me. 0.04 EPS for a biotech is a gooJack Hartmann-3/6/2000
262 Jack, IMO NABI is a "diamond in the rough"....Phase III product for sArthur Radley-3/6/2000
261 Nabi and the National Institute on Drug Abuse Initiate Toxicity Studies of Jack Hartmann-3/6/2000
260 new 52 week high today on very good volume $8 5/16peter a. pedroli-2/16/2000
259 institutions showing strong interest even merrill lynch has put nabi in 2 accoupeter a. pedroli-2/16/2000
258 NABI was also in news papers across the country ,AP and CBS nightly news in thepeter a. pedroli-12/19/1999
257 (COMTEX) B: NABI(R) RECEIVES PATENTS ON STAPHYLOCOCCUS EPIDERMIDIS VA B:Ken M-10/12/1999
256 yes i know my point is that it had only a 52% effectiveness rate. i have also rpeter a. pedroli-9/24/1999
255 yea, but this is Synercid man Cheeseburger-9/24/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News